Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm Sustainability Profile
Istituto Di Ricerche Biomediche Antoine Marxer RBM Spa, commonly referred to as RBM, is a prominent player in the biomedical research sector, headquartered in Italy. Established in the early 2000s, RBM has made significant strides in advancing healthcare solutions, particularly in the fields of clinical research and biostatistics. With a strong operational presence across Europe, RBM focuses on delivering innovative services that include data management, statistical analysis, and regulatory support for clinical trials. Their unique approach combines cutting-edge technology with a deep understanding of regulatory frameworks, ensuring high-quality outcomes for their clients. Recognised for their commitment to excellence, RBM has achieved notable milestones, positioning themselves as a trusted partner in the biomedical industry. Their dedication to advancing medical research continues to set them apart in a competitive market.
DitchCarbon Score
How does Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm, headquartered in Italy, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The organisation is a current subsidiary of Merck KGaA, which provides emissions data and climate commitments at a higher cascade level. While there are no direct reduction targets or climate pledges reported for Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm, it inherits sustainability initiatives from its parent company, Merck KGaA. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are aimed at reducing greenhouse gas emissions and enhancing transparency in climate-related performance. As a subsidiary, the organisation aligns with the broader climate strategies set forth by Merck KGaA, focusing on sustainable practices and emissions reduction across its operations. However, specific targets or achievements at the subsidiary level remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2006 | 2010 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 352,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 000,000,000 |
| Scope 2 | 402,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's Industry?
How Carbon Intensive is Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's Location?
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's Scope 3 Categories Breakdown
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's Scope 3 emissions, which decreased by 12% last year and increased significantly since 2010, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Istituto Di Ricerche Biomediche Antoine Marxer Rbm Spa Si Glabile Rbm has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
